Search Results

Advanced Brain Monitoring, Inc. today announced integration of its mobile, wireless 24-channel EEG system with the Stratus EEG cloud-based clinical software platform for home or hospital seizure monitoring.

Stratus® Medical, a company focused on improving clinical outcomes for chronic pain patients by advancing radiofrequency (RF) technology for the treatment of pain, announced today the issuance of its fifth U.S. patent (U.S. Patent No. 11,806,070) and first two Canadian patents (Canadian Patent Nos. 2,778,997 and 2,799,505) for the NIMBUS® Electrosurgical RF Multitined Expandable Electrode (“NIMBUS”).

Stratus® Medical and the University of Utah, Department of Physical Medicine and Rehabilitation, announced the first patient enrolled in the COBRA study, a double-blinded, randomized trial, comparing the bipolar treatment with Nimbus® RF Multitined Expandable Electrode to conventional radiofrequency ablation for the treatment of sacroiliac joint pain.

Adam Clarke, CEO and Principal Consultant of Stratus commented, “The projects that Nirvana Life Sciences are advancing represent the evolution of modern medicine.

Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.

Beacon Biosignals, which applies AI to EEG to unlock precision medicine for brain conditions, today announced a partnership with Stratus, the nation’s leading provider of EEG services, to enable expanded clinical trial service capabilities by leveraging Beacon’s machine learning neuroanalytics platform.

Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.

Stratus™ Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced three new patents today.